# Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial

> **NCT05309460** · PHASE4 · RECRUITING · sponsor: **Nebraska Methodist Health System** · enrollment: 600 (estimated)

## Conditions studied

- Postpartum Preeclampsia
- Hypertension in Pregnancy

## Interventions

- **DRUG:** Labetalol Oral Tablet
- **DRUG:** NIFEdipine ER

## Key facts

- **NCT ID:** NCT05309460
- **Lead sponsor:** Nebraska Methodist Health System
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-06-20
- **Primary completion:** 2024-05-01
- **Final completion:** 2024-12-01
- **Target enrollment:** 600 (ESTIMATED)
- **Last updated:** 2024-04-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05309460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05309460, "Labetalol or Nifedipine for Control of Postpartum Hypertension: A Randomized Controlled Trial". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05309460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*